Long-lasting effectiveness of intravenous immunoglobulin in a patient with inclusion-body myositis [7]

Annals of Internal Medicine

Volumn 134, Issue 12, 2001, Pages 1156-

  Mukunda, B N ^a   Kumar, P D ^a   Smith, H R ^a  

^a Huron Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G;

ADULT; CASE REPORT; CLINICAL FEATURE; DRUG EFFECT; DRUG EFFICACY; FEMALE; HUMAN; IMMUNE RESPONSE; IMMUNOTHERAPY; INCLUSION BODY MYOSITIS; LETTER; LONG TERM CARE; LYMPHOCYTE FUNCTION; MUSCLE STRENGTH; NATURAL KILLER CELL; PRIORITY JOURNAL; SUPPRESSOR CELL; SYMPTOM;

EID: 0035912732     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-134-12-200106190-00031     Document Type: Letter

References (4)

1. Treatment of inclusion-body myositis with high-dose intravenous immunoglobulin
2. The treatment of inclusion body myositis: A retrospective review and a randomized, prospective trial of immunosuppressive therapy
3. Inclusion body myositis
4. Inclusion body myositis presenting as treatment-resistant polymyositis